We provide the first evidence that chlorogenic acid mitigate colitis and prevent colitis-caused dysbiosis through inhibiting PKM2-dependent glycolysis, and thereby blocking Nlrp3 activation to shift the inflammatory M1 macrophage toward the anti-inflammatory M2 phenotype. The gene discussed is NLRP3; the disease is colitis.